Tacrolimus-resistant EBV-specific cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tacrolimus-resistant EBV-specific cytotoxic T lymphocytes, covering 2024-05-17 to 2024-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant [EARLY_Phase 1]